Ahmed M. Bayoumi

MD, MSc

Scientist

Biography

Dr. Ahmed Bayoumi is a Scientist at MAP Centre for Urban Health Solutions at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, where he is also a general internist and Human Immunodeficiency Virus (HIV) physician. He holds the Fondation Baxter and Alma Ricard Chair in Inner City Health at St. Michael’s Hospital and the University of Toronto and is a Professor in the Department of Medicine and in the Institute of Health Policy, Management and Evaluation at the University of Toronto. He is a Senior Adjunct Scientist at ICES. He has extensive experience in translating research to policy (member of the Canadian Drug Expert Committee, past Scientific Director of Converge3, past president of the international Society for Medical Decision Making, and past Director of Clinical Epidemiology and Health Care Research at the University of Toronto). He has co-led large multi-method studies, including the highly impactful Toronto and Ottawa Supervised Consumption Assessment (TOSCA) and the Marginalization and COVID-19 (MARCO) studies. His research interests include the delivery of health services, particularly to people who use drugs, people living with HIV, and other marginalized populations. He is a member of HMRAC (the Homelessness, Mortality, Research and Advocacy Coalition), an academic – community collaboration that meets regularly to discuss how research can address issues related to homelessness.

Recent Publications

  1. O'Brien, KK, Bayoumi, AM, Chan Carusone, S, Davis, AM, Aubry, R, Avery, L et al.. Disability and self-care living strategies among adults living with HIV during the COVID-19 pandemic. AIDS Res Ther. 2021;18 (1):87. doi: 10.1186/s12981-021-00413-4. PubMed PMID:34798881 PubMed Central PMC8604195.
  2. Ibrahim, YF, Refaie, MM, Kamel, MY, Ahmed, SM, Moussa, RA, Bayoumi, AM et al.. Molecular mechanisms underlying the effect of diacerein on trichloroacetic acid-induced hepatic pre-neoplastic lesions in rats. Hum Exp Toxicol. 2021;40 (12_suppl):S788-S803. doi: 10.1177/09603271211056331. PubMed PMID:34794354 .
  3. Tan, DHS, Rana, J, Tengra, Z, Hart, TA, Wilton, J, Bayoumi, AM et al.. Preferences regarding emerging HIV prevention technologies among Toronto men who have sex with men: a discrete choice experiment. Sci Rep. 2021;11 (1):22252. doi: 10.1038/s41598-021-01634-3. PubMed PMID:34782691 PubMed Central PMC8592986.
  4. Mohamed, EI, El-Ghnam, SM, Bayoumi, AM, Abdel-Mageed, SM, Ghareeb, DA, Ross, B et al.. Electronic nose versus quadrupole mass spectrometry for identifying viral hepatitis C patients. J Viral Hepat. 2022;29 (2):147-155. doi: 10.1111/jvh.13630. PubMed PMID:34773341 .
  5. Gomes, T, Kitchen, SA, Tailor, L, Men, S, Murray, R, Bayoumi, AM et al.. Trends in Hospitalizations for Serious Infections Among People With Opioid Use Disorder in Ontario, Canada. J Addict Med. 2021; :. doi: 10.1097/ADM.0000000000000928. PubMed PMID:34711742 .
  6. O'Brien, KK, Davis, AM, Chan Carusone, S, Avery, L, Tang, A, Solomon, P et al.. Examining the impact of a community-based exercise intervention on cardiorespiratory fitness, cardiovascular health, strength, flexibility and physical activity among adults living with HIV: A three-phased intervention study. PLoS One. 2021;16 (9):e0257639. doi: 10.1371/journal.pone.0257639. PubMed PMID:34559851 PubMed Central PMC8462727.
  7. O'Brien, KK, Bayoumi, AM, Carusone, SC, Davis, AM, Aubry, R, Avery, L et al.. Disability and Self-care Living Strategies Among Adults Living With HIV During the COVID-19 Pandemic. Res Sq. 2021; :. doi: 10.21203/rs.3.rs-868864/v1. PubMed PMID:34545356 PubMed Central PMC8452102.
  8. Mighton, C, Clausen, M, Sebastian, A, Muir, SM, Shickh, S, Baxter, NN et al.. Patient and public preferences for being recontacted with updated genomic results: a mixed methods study. Hum Genet. 2021;140 (12):1695-1708. doi: 10.1007/s00439-021-02366-0. PubMed PMID:34537903 .
  9. Refaie, MMM, Shehata, S, Ibrahim, RA, Bayoumi, AMA, Abdel-Gaber, SA. Dose-Dependent Cardioprotective Effect of Hemin in Doxorubicin-Induced Cardiotoxicity Via Nrf-2/HO-1 and TLR-5/NF-κB/TNF-α Signaling Pathways. Cardiovasc Toxicol. 2021;21 (12):1033-1044. doi: 10.1007/s12012-021-09694-7. PubMed PMID:34510376 .
  10. Perri, M, Kaminski, N, Bonn, M, Kolla, G, Guta, A, Bayoumi, AM et al.. A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone. Harm Reduct J. 2021;18 (1):85. doi: 10.1186/s12954-021-00530-3. PubMed PMID:34353323 PubMed Central PMC8339679.
Search PubMed

Affiliations & Other Activities

  • Scientist, MAP Centre for Urban Health Solutions, St. Michael’s Hospital
  • Professor, Department of Medicine, University of Toronto
  • Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
X